The NAD+ Precursor Nicotinamide Riboside Enhances Oxidative Metabolism and Protects against High-Fat Diet-Induced Obesity
Top Cited Papers
Open Access
- 6 June 2012
- journal article
- Published by Elsevier BV in Cell Metabolism
- Vol. 15 (6), 838-847
- https://doi.org/10.1016/j.cmet.2012.04.022
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Nicotinamide Mononucleotide, a Key NAD+ Intermediate, Treats the Pathophysiology of Diet- and Age-Induced Diabetes in MiceCell Metabolism, 2011
- Nicotinamide Phosphoribosyltransferase/Visfatin Does Not Catalyze Nicotinamide Mononucleotide Formation in Blood PlasmaPLOS ONE, 2011
- Pathways and Subcellular Compartmentation of NAD Biosynthesis in Human CellsOnline Journal of Public Health Informatics, 2011
- PARP-2 Regulates SIRT1 Expression and Whole-Body Energy ExpenditureCell Metabolism, 2011
- PARP-1 Inhibition Increases Mitochondrial Metabolism through SIRT1 ActivationCell Metabolism, 2011
- Calorie Restriction Reduces Oxidative Stress by SIRT3-Mediated SOD2 ActivationCell Metabolism, 2010
- Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator SREBPGenes & Development, 2010
- The Secret Life of NAD+: An Old Metabolite Controlling New Metabolic Signaling PathwaysEndocrine Reviews, 2010
- Circadian Clock Feedback Cycle Through NAMPT-Mediated NAD + BiosynthesisScience, 2009
- AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activityNature, 2009